EMA Recommends Granting a Marketing Authorisation for Nirogacestat By Ogkologos - July 3, 2025 324 0 Facebook Twitter Google+ Pinterest WhatsApp It is intended for the treatment of adult patients with progressing desmoid tumours Source RELATED ARTICLESMORE FROM AUTHOR Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors MOST POPULAR How Running and Training for a Marathon Helped Me Cope After... August 22, 2023 Can Eating Grilled or Charred Foods Cause Cancer? January 10, 2023 Survey results reveal attitudes towards cancer screening during the pandemic July 16, 2021 Doctors Said Egg-Sized Tumor Was Benign. A Year Later, She’s Fighting... July 16, 2021 Load more HOT NEWS Oncology Dietitians Don’t Usually Inquire About Food Insecurity in Cancer Patients,... Inguinofemoral Radiotherapy Could Spare Patients with Vulvar Cancer and Sentinel Node... Topical Diclofenac Gel Reduces the Incidence of Hand-Foot Syndrome in Patients... Progress in Treating Liver Cancer and Biliary Tract Cancer with Immunotherapy:...
